Human A20/TNFAIP3 Antibody Summary
Accession # P21580
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Detection of Human A20/TNFAIP3 by Western Blot. Western blot shows lysates of HepG2 human hepatocellular carcinoma cell line and NCI-H460 human large cell lung carcinoma cell line. PVDF membrane was probed with 2 µg/mL of Mouse Anti-Human A20/TNFAIP3 Monoclonal Antibody (Catalog # MAB7598) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for A20/TNFAIP3 at approximately 95 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
A20 (TNF alpha -induced protein 3) is a cytoplasmic zinc finger protein that inhibits NF kappa B activity and tumor necrosis factor-mediated programmed cell death. The protein interacts with NAF1 and inhibits TNF-induced NF kappa B-dependent gene expression by interfering with RIP- or TRAF2-mediated transactivation signaling. A20 contains an N-terminal domain which has deubiquitinating enzyme activity and removes ubiquitin chains from receptor-interacting protein (RIP), thus mediating distinct regulatory effects in the down-regulation of NF kappa B signaling.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Human A20/TNFAIP3 Antibody
There are currently no reviews for this product. Be the first to review Human A20/TNFAIP3 Antibody and earn rewards!
Have you used Human A20/TNFAIP3 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image